Finalizing display...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
(R)-Ro65-6570 | 3385 | None | 0 | Human | Binding | pKi | = | - | 9.60 | 1 | 8 | Unclassified | Guide to Pharmacology | 383.2 | 2 | 1 | 3 | 3.87 | O=C1NCN(c2ccccc2)C12CCN([C@@H]1Cc3cccc4cccc1c34)CC2 | https://pubmed.ncbi.nlm.nih.gov/10476866 | |
(R)-Ro65-6570 | 3385 | None | 0 | Human | Binding | Ki | = | 0.25 | 9.60 | 1 | 8 | Displacement of [3H]-orphanin FQ from human OrphaninFQ (hOFQ) receptor | ChEMBL | 383.2 | 2 | 1 | 3 | 3.87 | O=C1NCN(c2ccccc2)C12CCN([C@@H]1Cc3cccc4cccc1c34)CC2 | https://dx.doi.org/10.1016/s0960-894x(99)00385-6 | |
(R)-Ro65-6570 | 3385 | None | 0 | Rat | Binding | Ki | = | 0.41 | 9.39 | -1 | 8 | Inhibition against binding of radioligand [leucyl-3H]-OFQ to membrane of human embryonic kidney 293 cells overexpressing rat Opioid receptor like 1 | ChEMBL | 383.2 | 2 | 1 | 3 | 3.87 | O=C1NCN(c2ccccc2)C12CCN([C@@H]1Cc3cccc4cccc1c34)CC2 | https://dx.doi.org/10.1016/s0960-894x(00)00111-6 | |
17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[(4'-bromo)benzamido]morphinan-oxalate | 219960 | UNDEFINED | 0 | Human | Binding | pKi | = | 10000.00 | 5.00 | -1071519 | 4 | - | PDSP KiDatabase | 614.1 | 4 | 5 | 7 | 2.67 | O=C(NC1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5)c1ccc(Br)cc1.O=C(O)C(=O)O | - | |
17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[(4'-iodo)benzamido]morphinan-oxalate | 219961 | UNDEFINED | 0 | Human | Binding | pKi | = | 10000.00 | 5.00 | -2691 | 4 | - | PDSP KiDatabase | 662.1 | 4 | 5 | 7 | 2.52 | O=C(NC1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5)c1ccc(I)cc1.O=C(O)C(=O)O | - | |
17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[(4'-methyl)benzamido]morphinan-oxalate | 219958 | UNDEFINED | 0 | Human | Binding | pKi | = | 10000.00 | 5.00 | -245470 | 4 | - | PDSP KiDatabase | 550.2 | 4 | 5 | 7 | 2.22 | Cc1ccc(C(=O)NC2CCC3(O)C4Cc5ccc(O)c6c5C3(CCN4CC3CC3)C2O6)cc1.O=C(O)C(=O)O | - | |
17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[(4'-t-butyl)benzamido]morphinan-oxalate | 219962 | UNDEFINED | 0 | Human | Binding | pKi | = | 10000.00 | 5.00 | -2691 | 4 | - | PDSP KiDatabase | 592.3 | 4 | 5 | 7 | 3.21 | CC(C)(C)c1ccc(C(=O)NC2CCC3(O)C4Cc5ccc(O)c6c5C3(CCN4CC3CC3)C2O6)cc1.O=C(O)C(=O)O | - | |
17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[(4'-trimethylfluoro)benzamido]morphinan-oxalate | 219959 | UNDEFINED | 0 | Human | Binding | pKi | = | 4.20 | 8.38 | -9 | 4 | - | PDSP KiDatabase | 604.2 | 4 | 5 | 7 | 2.93 | O=C(NC1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5)c1ccc(C(F)(F)F)cc1.O=C(O)C(=O)O | - | |
[(pF)Phe4]N/OFQ-(1-13)-NH2 | 3073 | None | 0 | Human | Binding | pKi | = | - | 11.06 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/12070757 | |
[(pF)Phe4]N/OFQ-(1-13)-NH2 | 3073 | None | 0 | Human | Binding | pKi | = | - | 11.06 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/15743186 | |
[Arg14Lys15]N/OFQ | 467 | None | 15 | Human | Binding | pKi | None | - | 9.50 | - | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/11097863 | |
[Arg14Lys15]N/OFQ | 467 | None | 15 | Rat | Binding | IC50 | = | 0.21 | 9.68 | - | 2 | Displacement of [3H]nociceptin from rat ORL1 receptor expressed in african green monkey COS7 cells by competitive binding assay | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmc.2009.06.015 | |
[Arg14Lys15]N/OFQ | 467 | None | 15 | Rat | Binding | IC50 | = | 0.21 | 9.68 | - | 2 | Displacement of [3H]nociceptin from rat ORL1 receptor expressed in african green monkey COS7 cells | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmc.2008.09.014 | |
[F/G]N/OFQ-(1-13)-NH2 | 1636 | None | 0 | Human | Binding | pKi | None | - | 9.20 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/12967935 | |
[Met]enkephalin | 2495 | None | 37 | Guinea pig | Binding | Ki | = | 277.00 | 6.56 | -186 | 8 | Displacement of radiolabeled NalBzOH from kappa3 opioid receptor in Hartley guinea pig brain | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmcl.2006.05.060 | |
[Nphe1]N/OFQ-(1-13)-NH2 | 2875 | None | 0 | Human | Binding | pKi | None | - | 8.40 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/12010780 | |
Ac-RYYRIK-NH2 | 268 | None | 20 | Human | Binding | pKi | = | - | 8.96 | 1 | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/9353393 | |
Ac-RYYRIK-NH2 | 268 | None | 20 | Human | Binding | pKi | = | - | 8.96 | 1 | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/12967935 | |
Ac-RYYRIK-NH2 | 268 | None | 20 | Human | Binding | IC50 | = | 1.04 | 8.98 | 1 | 2 | Displacement of [3H]]nociceptin from human ORL1 receptor expressed in African green monkey COS7 cells after 90 mins by topcount analysis | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmc.2014.09.018 | |
Ac-RYYRIK-NH2 | 268 | None | 20 | Human | Binding | IC50 | = | 0.79 | 9.10 | 1 | 2 | Displacement of [3H]nociceptin from human ORL1-Galpha fusion receptor in COS7 cells | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmc.2007.11.043 |
Showing 1 to 20 of 2,070 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
(R)-Ro65-6570 | 3385 | None | 0 | Human | Functional | EC50 | = | 39.81 | 7.40 | - | 8 | Tested for potency to stimulate GTP-gamma 35S binding using membranes prepared from 293s cells transfected with the human OFQ receptor | ChEMBL | 383.2 | 2 | 1 | 3 | 3.87 | O=C1NCN(c2ccccc2)C12CCN([C@@H]1Cc3cccc4cccc1c34)CC2 | https://dx.doi.org/10.1016/s0960-894x(99)00385-6 | |
(R)-Ro65-6570 | 3385 | None | 0 | Human | Functional | pEC50 | = | - | 7.40 | - | 8 | Stimulation of GTP-γ35S binding | Guide to Pharmacology | 383.2 | 2 | 1 | 3 | 3.87 | O=C1NCN(c2ccccc2)C12CCN([C@@H]1Cc3cccc4cccc1c34)CC2 | https://pubmed.ncbi.nlm.nih.gov/10476866 | |
[(pF)Phe4]N/OFQ-(1-13)-NH2 | 3073 | None | 0 | Human | Functional | pEC50 | = | - | 10.12 | - | 1 | Stimulation of GTP-γ35S binding | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/15743186 | |
[Arg14Lys15]N/OFQ | 467 | None | 15 | Rat | Functional | EC50 | = | 1.10 | 8.96 | - | 2 | Agonist activity at rat ORL1 receptor expressed in african green monkey COS7 cells assessed as stimulation of [35S]GTPgammaS binding by radioligand receptor-binding assay | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmc.2009.06.015 | |
[Arg14Lys15]N/OFQ | 467 | None | 15 | Rat | Functional | EC50 | = | 1.10 | 8.96 | - | 2 | Activation of rat ORL1 receptor expressed in african green monkey COS7 cells by [35S]GTPgammaS binding assay | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmc.2008.09.014 | |
Ac-RYYRIK-NH2 | 268 | None | 20 | Human | Functional | pEC50 | = | - | 5.10 | - | 2 | Stimulation of GTP-γ35S binding | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/9353393 | |
Ac-RYYRIK-NH2 | 268 | None | 20 | Human | Functional | EC50 | = | 12.90 | 7.89 | - | 2 | Activity at human ORL1-Galpha fusion receptor in COS7 cells assessed as stimulation of [35S]GTP-gamma-S binding | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/j.bmc.2007.11.043 | |
Ac-RYYRWK-NH2 | 269 | None | 0 | Human | Functional | pEC50 | = | - | 8.68 | - | 2 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/9353393 | |
BUPRENORPHINE | 189274 | None | 0 | Human | Functional | EC50 | = | 116.00 | 6.94 | -954 | 8 | Partial agonist activity at human NOP receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting | ChEMBL | 467.3 | 4 | 2 | 5 | 4.41 | CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5 | https://dx.doi.org/10.1021/jm2003238 | |
BUPRENORPHINE | 189274 | None | 0 | Human | Functional | EC50 | = | 1480.00 | 5.83 | -954 | 8 | Agonist activity at human NOP receptor expressed in HEK293 cell membranes assessed as stimulation of [35S]GTPgammaS binding | ChEMBL | 467.3 | 4 | 2 | 5 | 4.41 | CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5 | https://dx.doi.org/10.1021/acs.jmedchem.5b00130 | |
cebranopadol | 877 | None | 42 | Human | Functional | pEC50 | = | - | 7.89 | -10 | 7 | Stimulation of GTP-γ35S binding | Guide to Pharmacology | 378.2 | 2 | 1 | 2 | 5.11 | CN(C)C1(c2ccccc2)CCC2(CC1)OCCc1c2[nH]c2ccc(F)cc12 | https://pubmed.ncbi.nlm.nih.gov/24713140 | |
cebranopadol | 877 | None | 42 | Human | Functional | EC50 | = | 13.00 | 7.89 | -10 | 7 | Agonist activity at human recombinant NOP receptor expressed in CHO-K1 cells assessed as stimulation of [35S]GTPgammaS binding by scintillation proximity assay | ChEMBL | 378.2 | 2 | 1 | 2 | 5.11 | CN(C)C1(c2ccccc2)CCC2(CC1)OCCc1c2[nH]c2ccc(F)cc12 | https://dx.doi.org/10.1021/ml500117c | |
CHEMBL101454 | 4410 | None | 15 | Human | Functional | EC50 | = | 19.90 | 7.70 | 4 | 3 | Concentration required for stimulation of [35S]GTP-gamma-S, binding to human Nociceptin receptor in cell membranes | ChEMBL | 326.2 | 2 | 0 | 2 | 4.15 | O=C1Cc2ccccc2N1C1CCN(C2CCCCCCC2)CC1 | https://dx.doi.org/10.1021/jm034249d | |
CHEMBL101454 | 4410 | None | 15 | Human | Functional | EC50 | = | 20.80 | 7.68 | 4 | 3 | Agonist activity at human nociceptin receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis | ChEMBL | 326.2 | 2 | 0 | 2 | 4.15 | O=C1Cc2ccccc2N1C1CCN(C2CCCCCCC2)CC1 | https://dx.doi.org/10.1016/j.bmcl.2013.03.101 | |
CHEMBL101676 | 4451 | None | 0 | Human | Functional | EC50 | = | 92.50 | 7.03 | - | 3 | Concentration required for stimulation of [35S]GTP-gamma-S, binding to human Nociceptin receptor in cell membranes | ChEMBL | 346.2 | 2 | 0 | 2 | 3.60 | O=C1Cc2ccccc2N1C1CCN(C2CCc3ccccc3C2)CC1 | https://dx.doi.org/10.1021/jm034249d | |
CHEMBL102900 | 4628 | None | 4 | Human | Functional | EC50 | = | 28.70 | 7.54 | -1 | 3 | Concentration required for stimulation of [35S]GTP-gamma-S, binding to human Nociceptin receptor in cell membranes | ChEMBL | 338.2 | 2 | 0 | 2 | 4.01 | O=C1Cc2ccccc2N1C1CCN(C2C3CCCC2CCC3)CC1 | https://dx.doi.org/10.1021/jm034249d | |
CHEMBL102900 | 4628 | None | 4 | Human | Functional | EC50 | = | 28.70 | 7.54 | -1 | 3 | Agonist activity at human nociceptin receptor transfected in CHO cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting analysis | ChEMBL | 338.2 | 2 | 0 | 2 | 4.01 | O=C1Cc2ccccc2N1C1CCN(C2C3CCCC2CCC3)CC1 | https://dx.doi.org/10.1016/j.bmcl.2013.03.101 | |
CHEMBL1076208 | 5489 | None | 0 | Human | Functional | IC50 | = | 448.00 | 6.35 | - | 2 | Agonist activity at human NOP receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 2 hrs | ChEMBL | 413.3 | 4 | 1 | 4 | 3.90 | CNC(=O)CN1C(=O)OC2(CCN(C3CCC(C(C)C)CC3)CC2)c2ccccc21 | https://dx.doi.org/10.1016/j.bmcl.2009.09.028 | |
CHEMBL1076242 | 5496 | None | 0 | Human | Functional | IC50 | = | 21.00 | 7.68 | - | 2 | Agonist activity at human NOP receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 2 hrs | ChEMBL | 448.3 | 5 | 1 | 4 | 2.98 | CNC(=O)CN1c2ccccc2N(C2CCN(C3CCC(C(C)C)CC3)CC2)S1(=O)=O | https://dx.doi.org/10.1016/j.bmcl.2009.09.028 | |
CHEMBL1079400 | 5870 | None | 0 | Human | Functional | IC50 | = | 5.20 | 8.28 | - | 2 | Agonist activity at human NOP receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production after 2 hrs | ChEMBL | 476.3 | 4 | 1 | 4 | 3.66 | CNC(=O)CN1Cc2ccccc2N(C2CCN(C3CCCCCCCCC3)CC2)S1(=O)=O | https://dx.doi.org/10.1016/j.bmcl.2009.09.028 |
Showing 1 to 20 of 675 entries